Pharmacological Modulation of Ferroptosis As a Therapeutic Target for Liver Fibrosis

Overview

Journal Front Pharmacol

Date 2023 Jan 27

PMID 36703745

Authors

Le Li

Zhijun Zhu

Affiliations

Soon will be listed here.

Abstract

Liver fibrosis, which is characterized by the excessive deposition of extracellular matrix (ECM) materials (primarily fibrillar collagen-I), is an abnormal repair reaction and pathological outcome of chronic liver diseases caused by alcohol abuse, non-alcoholic fatty liver disease, and chronic hepatitis B and C virus infections. Liver fibrosis often progresses to liver cirrhosis and hepatocellular carcinoma. Ferroptosis, characterized by lipid peroxidation, is a form of iron-dependent non-apoptotic cell death, and recent studies have reported that ferroptosis contribute to the development of liver fibrosis. Moreover, several agents have demonstrated therapeutic effects in experimental liver fibrosis models by inducing hepatic stellate cell (HSCs) ferroptosis. This review delineates the specific mechanism by which ferroptosis contributes to the development of liver fibrosis. Specifically, we focused on the different types of therapeutic agents that can induce HSCs ferroptosis and summarize their pharmacological effectiveness for liver fibrosis treatment. We suggest that HSCs ferroptosis may be a potential useful target of novel therapies for preventing and treating liver fibrosis.

Citing Articles

Yunnan medicine Jiangzhi ointment alleviates hyperlipid-induced hepatocyte ferroptosis by activating AMPK and promoting autophagy.

Hong X, Liu H, Sun H, Zhuang Y, Xiao M, Li S Cytotechnology. 2025; 77(2):73.

PMID: 40062225 PMC: 11883071. DOI: 10.1007/s10616-025-00737-3.

Diagnostic Utility of Serum Ferritin in Identifying Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A Cross-Sectional Study Using National Health and Nutrition Examination Survey (NHANES-2017-2020) Data.

Ramasamy J Indian J Clin Biochem. 2025; 40(1):80-88.

PMID: 39835224 PMC: 11741978. DOI: 10.1007/s12291-023-01159-8.

Sodium aescinate-induced hepatotoxicity via ATF4/GSH/GPX4 axis-mediated ferroptosis.

Xi C, Zhou J, Zheng X, Fu X, Xie M Sci Rep. 2025; 15(1):1141.

PMID: 39774712 PMC: 11706965. DOI: 10.1038/s41598-024-79723-2.

Machine Learning and Experimental Validation Identified Ferroptosis Signature and Innovative Biomarkers (ESR1 and GSTZ1) in Liver Fibrosis.

Luo W, Wu H, Yang Z, Lan T, Wu L, Huang Y J Inflamm Res. 2024; 17:10313-10332.

PMID: 39649424 PMC: 11625426. DOI: 10.2147/JIR.S490258.

Available and novel plant-based carbon dots derived from Vaccaria Semen carbonisata alleviates liver fibrosis.

Zhao Y, Dai E, Dong L, Yuan J, Zhao Y, Wu T Front Mol Biosci. 2023; 10:1282929.

PMID: 38116381 PMC: 10729316. DOI: 10.3389/fmolb.2023.1282929.

References

Fallowfield J, Mizuno M, Kendall T, Constandinou C, Benyon R, Duffield J . Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol. 2007; 178(8):5288-95. DOI: 10.4049/jimmunol.178.8.5288. View

Tan Z, Sun H, Xue T, Gan C, Liu H, Xie Y . Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front Cell Dev Biol. 2021; 9:730176. PMC: 8490799. DOI: 10.3389/fcell.2021.730176. View

Luo P, Liu D, Zhang Q, Yang F, Wong Y, Xia F . Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis targeting peroxiredoxins and HO-1. Acta Pharm Sin B. 2022; 12(5):2300-2314. PMC: 9136576. DOI: 10.1016/j.apsb.2021.12.007. View

Song J, An J, Chen Q, Yang X, Jia C, Xu S . Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice. Bioengineered. 2022; 13(4):8334-8348. PMC: 9161873. DOI: 10.1080/21655979.2022.2051858. View

Senoo H, Kojima N, Sato M . Vitamin A-storing cells (stellate cells). Vitam Horm. 2007; 75:131-59. DOI: 10.1016/S0083-6729(06)75006-3. View

Luan S, Yang Y, Ye M, Liu H, Rao Q, Kong J . ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p/BTG1 pathway. Int J Biol Macromol. 2022; 211:128-139. DOI: 10.1016/j.ijbiomac.2022.05.041. View

Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

Zhang Z, Guo M, Shen M, Kong D, Zhang F, Shao J . The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells. Redox Biol. 2020; 36:101619. PMC: 7330619. DOI: 10.1016/j.redox.2020.101619. View

Ho C, Huang J, Sun M, Tzeng I, Hsu Y, Kuo C . Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis. Evid Based Complement Alternat Med. 2021; 2021:6671129. PMC: 8241502. DOI: 10.1155/2021/6671129. View

10.

Gao B, Bataller R . Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141(5):1572-85. PMC: 3214974. DOI: 10.1053/j.gastro.2011.09.002. View

11.

Zhou L, Li Y, Liang Q, Liu J, Liu Y . Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review. J Drug Target. 2022; 30(6):577-588. DOI: 10.1080/1061186X.2022.2044485. View

12.

Kong Z, Liu R, Cheng Y . Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway. Biomed Pharmacother. 2018; 109:2043-2053. DOI: 10.1016/j.biopha.2018.11.030. View

13.

Peng W, Cheng S, Bao Z, Wang Y, Zhou W, Wang J . Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomed Pharmacother. 2021; 137:111342. DOI: 10.1016/j.biopha.2021.111342. View

14.

Koyama Y, Wang P, Liang S, Iwaisako K, Liu X, Xu J . Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis. J Clin Invest. 2017; 127(4):1254-1270. PMC: 5373891. DOI: 10.1172/JCI88845. View

15.

Luo X, Luo S, Xu Z, Zhou C, Li Z, Zhou X . Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease. World J Gastroenterol. 2021; 27(14):1419-1434. PMC: 8047533. DOI: 10.3748/wjg.v27.i14.1419. View

16.

Ebrahimi H, Naderian M, Sohrabpour A . New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2018; 10(3):133-148. PMC: 6119836. DOI: 10.15171/mejdd.2018.103. View

17.

Moles A, Murphy L, Wilson C, Bagchi Chakraborty J, Fox C, Park E . A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. J Hepatol. 2013; 60(4):782-91. PMC: 3960359. DOI: 10.1016/j.jhep.2013.12.005. View

18.

Shi Y, Yan T, Lu X, Li K, Nie Y, Jiao C . Phloridzin Reveals New Treatment Strategies for Liver Fibrosis. Pharmaceuticals (Basel). 2022; 15(7). PMC: 9321461. DOI: 10.3390/ph15070896. View

19.

Pan Q, Luo Y, Xia Q, He K . Ferroptosis and Liver Fibrosis. Int J Med Sci. 2021; 18(15):3361-3366. PMC: 8436108. DOI: 10.7150/ijms.62903. View

20.

Friedman S . Liver fibrosis -- from bench to bedside. J Hepatol. 2003; 38 Suppl 1:S38-53. DOI: 10.1016/s0168-8278(02)00429-4. View